πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors β€” phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β€” searchable for business development and competitive intelligence.

4,838 results for β€œSP” Clear

  1. rhTPO

    The First People's Hospital of Lianyungang

    Thrombocytopenia

    approved small molecule active

    1 trial

  2. risperidone

    Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co.,

    Neuroleptic-Induced Tardive Dyskinesia

    approved small molecule completed

    1 trial

  3. rituximab combined with corticosteroids

    The First People's Hospital of Lianyungang

    Primary Membranous Nephropathy

    approved small molecule active

    1 trial

  4. ropivacaine

    The First People's Hospital of Lianyungang

    Injury of Upper Limb

    approved small molecule completed

    1 trial

  5. sIPV+DTaP+HepA

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Vaccination

    approved mab active

    1 trial

  6. seasonal split influenza vaccine

    Sinovac Research and Development Co.,

    Influenza

    approved mab completed

    1 trial

  7. semaglutide combined with metformin

    The First People's Hospital of Lianyungang

    Osteoporosis

    approved small molecule active

    1 trial

  8. silk suture

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Breast Cancer

    approved other completed

    1 trial

  9. sodium valproate

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Epilepsy

    approved small molecule active

    1 trial

  10. sodium zirconium cyclic silicate

    The First People's Hospital of Lianyungang

    Potassium Imbalance

    approved small molecule active

    1 trial

  11. split-virion, adjuvanted H1N1 vaccine of 7.5 ΞΌg per dose

    Sinovac Research and Development Co.,

    Influenza

    approved mab completed

    1 trial

  12. tacrolimus

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Moderate/Severe Atopic Dermatitis

    approved small molecule completed

    1 trial

  13. telbivudine (ROADMAP)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hepatitis B, Chronic

    approved small molecule active

    1 trial

  14. ticagrelor

    The First People's Hospital of Lianyungang

    Inflammation

    approved small molecule completed

    1 trial

  15. ticagrelor + ASA

    Peking University Third Hospital

    Cerebrovascular Accident

    approved small molecule completed

    1 trial

  16. tong-jiang granules

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Non-erosive Reflux Disease/Diarrheal Irritable Bowel Syndrome

    approved small molecule active

    1 trial

  17. treatment with CAZ-AVI

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Patients With Critically Ill Infections

    approved small molecule active

    1 trial

  18. ulinastatin

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Pancreatitis

    approved small molecule on hold

    1 trial

  19. vaccinated with Sabin IPV

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Polio

    approved mab completed

    1 trial

  20. video capsule endoscopy

    Hospital Authority, Hong Kong

    Overt Obscure Gastrointestinal Bleeding

    approved other completed

    1 trial

  21. 0 ul of ondansetron

    Hospital Authority, Hong Kong

    Blood Coagulation Disorder

    small molecule active

    1 trial

  22. 0.01% concentration atropine drops

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Acupressure

    small molecule active

    1 trial

  23. 0.1% bromfenac ophthalmic solution

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Cataract

    small molecule completed

    1 trial

  24. 0.9% NaCl physiological saline

    Hospital Authority, Hong Kong

    Acute Respiratory Tract Infections

    small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β€” verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources